Candesartan is an oral angiotensin II receptor blocker. The FDA approved candesartan for the management of hypertension in adults. It is available as a pro-drug, candesartan cilexetil, which undergoes hydrolysis in the gastrointestinal tract during absorption to its active form. Candesartan is also used off-label to treat conditions including cerebrovascular accident or stroke, diabetic nephropathy, left ventricular hypertrophy, and migraines. This activity reviews the mechanism of action, adverse event profile, toxicity, dosing, pharmacodynamics, and monitoring of candesartan, pertinent for clinicians and other interprofessional team members so that this drug can be utilized when indicated.

**Objectives:**
- Identify the indications, both approved and off-label, of candesartan.
- Review the mechanism of action of candesartan.
- Outline the potential adverse effects of candesartan.
- Summarize the importance of collaboration and communication among interprofessional team members to improve outcomes and treatment efficacy for patients receiving treatment with candesartan.